Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) - PAR-25-225
Funder
National Institutes of Health
LOI Required
No
Application Deadline
;
;
;
;
;
;
;
Maximum Project Duration
3 years
Research Focus Areas
Bipolar Disorders
Alzheimer’s Disease, Dementia, and Neurocognitive Disorders
Neurobiology/Neuroscience
Pharmacotherapy
Pharmacology
Research Methods
Quantitative Research Methods
Description
This Notice of Funding Opportunity (NOFO) provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological disorders that fall under the NINDS mission. Therapeutic agents include small molecules or biologics. This NOFO is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE).